A phase 2 study has suggested that the glycoprotein (gp) IIb/IIIa blocker eptifibatide can be safely combined with a reduced dose of tPA in the treatment of acute ischemic stroke, and there was a ...

PRAGUE, Czech Republic — A 0.4-mg/kg bolus dose of tenecteplase (TNKase, Genentech) was associated with functional outcomes and safety similar to those seen with the standard of care, alteplase ...

Administering intra-arterial tissue plasminogen activator (tPA; alteplase) after successful thrombectomy boosts outcomes in patients with acute ischemic strokes caused by large-vessel occlusions, the ...

(HealthDay News) — Blacks, Hispanics, women, seniors on Medicare, and patients in rural areas are less likely to be treated with tissue plasminogen activator (tPA) after stroke, according to research ...

An experimental therapy using tiny bubbles activated by transcranial doppler ultrasound combined with the clot busting drug tissue plasminogen activator (tPA) is more effective than tPA alone in ...

Among patients presenting directly to a thrombectomy-equipped center with a large-vessel ischemic stroke, going directly to the endovascular suite and forgoing initial IV thrombolytic therapy provides ...

And let's get some health news now. New studies about recovery from strokes appear in this week's Journal of the American Medical Association. The research suggests hospitals can save lives and reduce ...

Every minute counts during a stroke. Experts say early diagnosis and prompt treatment can reverse paralysis and prevent ...

CEDAR RAPIDS - Julie McGraw doesn't have diabetes, has no family history or any other risk factors that could have indicated to her she was at risk for a stroke. But in February 2018, an odd sensation ...